Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Nathan Denlinger"'
Autor:
Wing Keung Chan, Jessica Williams, Kinnari Sorathia, Betsy Pray, Kaled Abusaleh, Zehua Bian, Archisha Sharma, Ian Hout, Shamama Nishat, Walter Hanel, Shelby L. Sloan, Aneeq Yasin, Nathan Denlinger, Xiaoli Zhang, Natarajan Muthusamy, Sumithira Vasu, Marcos de Lima, Yiping Yang, Robert Baiocchi, Lapo Alinari
Publikováno v:
Experimental Hematology & Oncology, Vol 12, Iss 1, Pp 1-15 (2023)
Abstract Background Mantle cell lymphoma (MCL) is a rare B-cell non-Hodgkin lymphoma subtype which remains incurable despite multimodal approach including chemoimmunotherapy followed by stem cell transplant, targeted approaches such as the BTK inhibi
Externí odkaz:
https://doaj.org/article/71313e0e10e94b959e6046c399c56a84
Autor:
David Bond, Vedat Yildiz, Lai Wei, John Reneau, Yazeed Sawalha, Beth Christian, Jonathan Brammer, Jean Koff, Narendranath Epperla, Aubree Dendorfer, Lily Yang, Baiocchi Robert, Timothy Voorhees, Audrey Sigmund, Walter Hanel, Polina Shindiapina, Nathan Denlinger, Sam Penza, Samantha Jaglowski, Evandro Bezerra, Lapo Alinari, Kristie Blum, Kami Maddocks
Publikováno v:
HemaSphere, Vol 7, p e1419630 (2023)
Externí odkaz:
https://doaj.org/article/da38701602044bb1978ec66433e41231
Autor:
Joseph H. Azar, John P. Evans, Madison H. Sikorski, Karthik B. Chakravarthy, Selah McKenney, Ian Carmody, Cong Zeng, Rachael Teodorescu, No-Joon Song, Jamie L. Hamon, Donna Bucci, Maria Velegraki, Chelsea Bolyard, Kevin P. Weller, Sarah A. Reisinger, Seema A. Bhat, Kami J. Maddocks, Nathan Denlinger, Narendranath Epperla, Richard J. Gumina, Anastasia N. Vlasova, Eugene M. Oltz, Linda J. Saif, Dongjun Chung, Jennifer A. Woyach, Peter G. Shields, Shan-Lu Liu, Zihai Li, Mark P. Rubinstein
Publikováno v:
JCI Insight, Vol 8, Iss 6 (2023)
We assessed vaccine-induced antibody responses to the SARS-CoV-2 ancestral virus and Omicron variant before and after booster immunization in 57 patients with B cell malignancies. Over one-third of vaccinated patients at the pre-booster time point we
Externí odkaz:
https://doaj.org/article/094df6d1a4bf45e8b2832d1cf020148e
Autor:
Joanna Zurko, Jeremy Ramdial, Mazyar Shadman, Sairah Ahmed, Aniko Szabo, Lorenzo Iovino, Ana Alarcon Tomas, Craig Sauter, Miguel-Angel Perales, Nirav. N. Shah, Utkarsh H. Acharya, Caron Jacobson, Robert J. Soiffer, Trent Wang, Krishna V. Komanduri, Samantha Jaglowski, Adam S. Kittai, Nathan Denlinger, Madiha Iqbal, Mohamed A. Kharfan-Dabaja, Ernesto Ayala, Julio Chavez, Michael Jain, Frederick L. Locke, Yazeed Samara, Lihua E. Budde, Matthew G. Mei, Alexandra Della Pia, Tatyana Feldman, Nausheen Ahmed, Ryan Jacobs, Nilanjan Ghosh, Bhagirathbhai Dholaria, Olalekan O. Oluwole, Brian Hess, Ayesha Hassan, Vaishalee P. Kenkre, Patrick Reagan, Farrukh Awan, Yago Nieto, Mehdi Hamadani, Alex F. Herrera
Publikováno v:
Haematologica, Vol 108, Iss 1 (2022)
Allogeneic hematopoietic cell transplantation (alloHCT) can potentially salvage large B-cell lymphoma (LBCL) patients experiencing treatment failure after chimeric antigen receptor T-cell therapy (CAR T). Nonetheless, data on the efficacy and toxicit
Externí odkaz:
https://doaj.org/article/79e2386110cd4911812ba846c2081e54
Autor:
Avirup Guha, Lai Wei, Sumithira Vasu, Daniel Addison, Jonathan E Brammer, Zachary Braunstein, Aashish Katapadi, Kyle Porter, Michael Biersmith, Vedat O Yildiz, Sakima A Smith, Benjamin Buck, Devin Haddad, Richard Gumina, Basem M William, Sam Penza, Ayman Saad, Nathan Denlinger, Ajay Vallakati, Ragavendra Baliga, Raymond Benza, Philip Binkley, Mason Mocarski, Steven M Devine, Samantha Jaglowski
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 8 (2021)
Externí odkaz:
https://doaj.org/article/0549dc4da85f4345b069b254b508c05d
Publikováno v:
Cancers, Vol 14, Iss 16, p 3972 (2022)
Cancer immunotherapy has revolutionized the field of oncology in recent years. Harnessing the immune system to treat cancer has led to a large growth in the number of novel immunotherapeutic strategies, including immune checkpoint inhibition, chimeri
Externí odkaz:
https://doaj.org/article/f051612c2c7c4e54bb195c3481bbfe5b
Autor:
H. Moses Murdock, Haesook T. Kim, Nathan Denlinger, Pankit Vachhani, Bryan Hambley, Bryan S. Manning, Shannon Gier, Christina Cho, Harrison K. Tsai, Shannon McCurdy, Vincent T. Ho, John Koreth, Robert J. Soiffer, Jerome Ritz, Martin P. Carroll, Sumithira Vasu, Miguel-Angel Perales, Eunice S. Wang, Lukasz P. Gondek, Steven Devine, Edwin P. Alyea, R. Coleman Lindsley, Christopher J. Gibson
Publikováno v:
Blood
Older patients with acute myeloid leukemia (AML) have high relapse risk and poor survival after allogeneic hematopoietic cell transplantation (HCT). Younger patients may receive myeloablative conditioning to mitigate relapse risk associated with high
Autor:
Amneet Bajwa, Ying Huang, Rui Li, Nathan Denlinger, Jonathan Brammer, Sam Penza, Ayman Saad, Samantha Jaglowski, Adam S. Kittai
Publikováno v:
Leuk Lymphoma
Autor:
Joanna C Zurko, Imran Nizamuddin, Narendranath Epperla, Kevin A David, Jonathon B. Cohen, Tamara Moyo, Thomas A Ollila, Brian T. Hess, Ishan Roy, Robert Ferdman, Jieqi Liu, Sayan Mullick Chowdhury, Jason T. Romancik, Rahul S Bhansali, Elyse I. Harris, Mckenzie Sorrell, Rebecca Masel, Adam S Kittai, Nathan Denlinger, Audrey M Sigmund, Lindsey A. Fitzgerald, Carlos Galvez, Shuo Ma, Jane N Winter, Barbara Pro, Leo I Gordon, Alexey V Danilov, Deborah M. Stephens, Nirav N Shah, Vaishalee P Kenkre, Stefan K Barta, Pallawi Torka, Geoffrey Shouse, Reem Karmali
Publikováno v:
Blood Advances.
Most patients receiving CAR T-cell therapy (CAR-T) for aggressive B-cell lymphoma (B-NHL) will not experience a durable remission. There are several novel agents approved for the treatment relapsed, refractory aggressive B-NHL; however, it remains un
Autor:
Sumithira Vasu, Lapo Alinari, Nicole Szuminski, Dina Schneider, Nathan Denlinger, Wing Keung Chan, Khalid Parris, Nidhi Sharma, Hillary Bradbury, Beth Daneault, Lynn O'Donnell, Boro Dropulic, Marcos J.G. de Lima
Publikováno v:
Blood. 140:7474-7475